Australia's Monash IVF faces worst year ever on embryo mix-ups, collapsed takeover offer
** Shares of Monash IVF Group MVF.AX fall 1% to A$0.733 ** Fertility services provider down ~42% for the year, heading for its worst year ever ** Last week, a takeover offer valuing the company at $209 million from a consortium was withdrawn ** The year also saw two embryo mix-up incidents at Monash's fertility clinics, leading to the departure of then CEO and MD Michael Knaap (Reporting by John Biju in Bengaluru) ((John.Biju@thomsonreuters.com;))
Recent news on Monash IVF
See all newsBrief: Monash IVF Group Appoints Matt Harrington As Chief Financial Officer
Australia's Monash IVF at over four-month high on upbeat FY27 outlook
Brief: Monash IVF Group Posts FY Revenue AUD 269.5 Million
Brief: Monash IVF Group Appoints Catherine West As Chair-Elect
Brief: Memphasys Executes Supply Agreement With Monash IVF Group